Jeevan Scientific Technology Ltd is an Independent Clinical Contract Research Organization which offers technology-driven clinical research solutionsServices Offered: a) Clinical Trial Services: Patient PK trials, Pharmacodynamic endpoint studies, Early & late phase clinical trials, Post-marketing surveillance studies, Investigator initiated and real-world evidence studies, Clinical Trials Support for Complex…
Jeevan Scientific Technology's board approved the financial results for the quarter. Standalone revenue was ₹8.22 Cr with a net loss of ₹2.16 Cr. Consolidated revenue stood at ₹8.80 Cr, showing a net loss of ₹3.22 Cr. The board re-appointed Mr. Krishna Kishore Kuchipudi as MD for three years and appointed...
Jeevan Scientific Technology Limited has announced a board meeting today. The board approved the financial results for the quarter, reporting a consolidated loss of 3.22 Cr, compared to a profit of 1.03 Cr in the same quarter last year. Key management changes include the re-appointment of Mr. Krishna Kishore Kuchipudi...
Jeevan Scientific Technology Limited has announced a board meeting on August 14, 2025. This meeting was originally scheduled for August 7, 2025. The purpose of this board meeting is to consider the financial results for the quarter ended June 30, 2025. The postponement means that stakeholders tracking the company's performance...
Jeevan Scientific Technology announced the successful processing of dematerialization requests for the quarter ended June 30, 2025. Its Registrar and Share Transfer Agent, CIL Securities Limited, confirmed that all physical shares submitted for electronic conversion were processed efficiently. This includes promptly confirming shares to depositories, ensuring they are listed on...
Jeevan Scientific Technology Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company shared standalone and consolidated audited financial results, reflecting its operational and financial performance. This step underscores transparency and timely communication to shareholders, which is vital for assessing the company’s...
